Amelioration of Graft versus Host Disease with Anti-ICAM-1 Therapy
- 31 December 1998
- journal article
- Published by Elsevier BV in Journal of Surgical Research
- Vol. 80 (2), 280-286
- https://doi.org/10.1006/jsre.1998.5422
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Increased intestinal permeability in rats with graft versus host disease.Gut, 1996
- Monoclonal antibodies against ICAM‐1 and LFA‐1 prolong nerve allograft survivalMuscle & Nerve, 1995
- The effect of anti-ICAM-1 monoclonal antibody treatment on the transplantation of the small bowel in ratsJournal of Pediatric Surgery, 1993
- Soluble Intercellular Adhesion Molecule‐1 (ICAM‐1) Antigen in Patients with Rheumatoid ArthritisScandinavian Journal of Immunology, 1993
- PREVENTION OF GRAFT-VERSUS-HOST DISEASE IN RAT SMALL BOWEL TRANSPLANTATION BY RECIPIENT PRETREATMENT WITH UV-B-MODULATED BONE MARROW CELLSTransplantation, 1993
- A PHASE I TRIAL OF IMMUNOSUPPRESSION WITH ANTIIC AM-1 (CD54) mAb IN RENAL ALLOGRAFT RECIPIENTSTransplantation, 1993
- Specific Acceptance of Cardiac Allograft After Treatment with Antibodies to ICAM-1 and LFA-1Science, 1992
- Characterization of the rat leukocyte integrin, CD11/CD18, by the use of LFA‐1 subunit‐specific monoclonal antibodiesEuropean Journal of Immunology, 1991
- GRAFT-VERSUS-HOST DISEASE ASSOCIATED WITH INTESTINAL TRANSPLANTATION IN THE RAT HOST IMMUNE FUNCTION AND GENERAL HISTOLOGYTransplantation, 1989
- GRAFT-VERSUS-HOST DISEASE INDUCED BY SMALL BOWEL ALLOGRAFTSTransplantation, 1986